Ming Pan, M.Sc, M.D., F.R.C.P (C)

Position: Radiation QA Physician Lead
Affiliation: ESC Regional Cancer Program

Position: Radiation Oncologist
Affiliation: Windsor Regional Hospital Cancer Program

Position: Adjunct Professor, Dept. of Oncology
Affiliation: Schulich School of Medicine & Dentistry, University of Western Ontario

Position: Adjunct Professor, Dept. of Physics
Affiliation: University of Windsor

E-mail: wcrg@uwindsor.ca

Website: www.wrh.on.ca/cancerprogram

Areas of Expertise: lung, genitourinary, gastrointestinal, skin, head and neck malignancies.

Brief Description of Research:

Since 1998, Dr. Ming Pan has acquired over 20 years of experience practicing radiation oncology in 3 continents. He treats high volume of lung, GU, GI, skin, head and neck malignancies and is continuously involved in clinical research while teaching residents and medical students.

Dr. Pan is the Principal Investigator (PI), local PI, or co-investigator on numerous research studies at all times.
Currently he is focused on research in the following areas:

  • Artificial Intelligence in the Radiation Treatment Planning Process for Cancer; Functional Lung Surrogates in Radiation Therapy Planning CT Scans
  • Clinical trials for patients with advanced oropharyngeal cancer, localized prostate cancer, and inoperable Stage I Non-Small Cell Lung Cancer
  • Feasibility studies for specific therapies for patients with prostate cancer and a number of quality of life projects.

5 Selected Publications:

Pan, M. and Agapito, J. (2019). Can we use Hounsfield Unit Ranges as Surrogates for Functional Lung Avoidance in 4-Dimensional Computerized Tomography Simulation Datasets: A Pilot Study. Abstract accepted as poster presentation for the CARO 2019 Annual Scientific Meeting in Halifax, NS, October 2-5.

Sur, R., Falkson, C., Pan, M. et al. (2017). A Phase III, Multi-centre, Randomized Trial to Evaluate the Symptomatic and Quality of Life Improvements in Lung Cancer Patients Receiving External Beam Radiation (EBR) With or Without High Dose Rate Intraluminal Brachytherapy (HDRILB).” Abstract and oral Scientific Session for the American Society for Radiation Oncology (ASTRO) 59th Annual Meeting, San Diego, CA, USA, September 24-27

Pan, M., Schneider, K., Kulkarni, S., et al. (2014). Head and Neck Cancer Outcome in Windsor Ontario: A Border City Single Institution Experience. Cureus. CARO 2014 Annual Scientific Meeting-Outcomes: Clinical and Professional – Success for our Patient and Ourselves, St. John’s, Newfoundland, Canada.

PanM., Schneider, K., Kulkarni, S., et al. Outcome of Stage 4A and 4B Head and Neck Squamous Cell Carcinoma: A Single Institution Experience with Intensity Modulated Radiotherapy and Volumetric Modulated ARC Therapy. Radiation and Oncology, 120(1), (2016): S54. http://dx.doi.org/10.1016/S0167-8140(16)33546-0

Pan, M., Lukka, H., Corbett, T., Patel, M., Tsakiridis, T., and Dayes, I. (2008). Influence of Gold Seed Implantation on Defining Target Volumes for Conformal Radiotherapy of Prostate Cancer.” International Journal of Radiation Oncology • Biology • Physics (IJROBP). ASTRO’s 50th Annual Meeting, Boston, United States (S322-322). Elsevier, United States. http://dx.doi.org/10.1016/j.ijrobp.2008.06.1105